See more : Innofactor Oyj (IFA1V.HE) Income Statement Analysis – Financial Results
Complete financial analysis of e-therapeutics plc (ETXPF) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of e-therapeutics plc, a leading company in the Biotechnology industry within the Healthcare sector.
You may be interested
- Lakeland Financial Corporation (LKFN) Income Statement Analysis – Financial Results
- Tein, Inc. (7217.T) Income Statement Analysis – Financial Results
- Accustem Sciences Inc. (ACUT) Income Statement Analysis – Financial Results
- MLG Oz Limited (MLG.AX) Income Statement Analysis – Financial Results
- Eline Entertainment Group, Inc. (EEGI) Income Statement Analysis – Financial Results
e-therapeutics plc (ETXPF)
About e-therapeutics plc
e-Therapeutics plc engages in drug discovery research activities in the United Kingdom. Its computational platform provides in silico screens generate predictions on compounds and/or targets that can have a significant perturbative effect on the biology of interest, captured by its network models, as well as developing RNAi platform for highly specific gene silencing. The company was incorporated in 2001 and is based in London, the United Kingdom.
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 318.00K | 475.00K | 641.42K | 435.30K | 601.10K | 57.88K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 67.00K | 64.00K | 0.00 |
| Cost of Revenue | 0.00 | 0.00 | 164.42K | 118.30K | 145.10K | 13.88K | 88.17K | 70.45K | 103.55K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 5.00K | 24.00K | 0.00 |
| Gross Profit | 318.00K | 475.00K | 477.00K | 317.00K | 456.00K | 44.00K | -88.17K | -70.45K | -103.55K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 62.00K | 40.00K | 0.00 |
| Gross Profit Ratio | 100.00% | 100.00% | 74.37% | 72.82% | 75.86% | 76.02% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 92.54% | 62.50% | 0.00% |
| Research & Development | 10.25M | 8.90M | 8.21M | 3.71M | 2.77M | 4.83M | 7.14M | 13.73M | 14.14M | 8.55M | 5.37M | 4.09M | 2.90M | 1.68M | 1.69M | 1.00M | 1.14M | 0.00 |
| General & Administrative | 3.86M | 3.48M | 3.94M | 2.10M | 1.24M | 1.49M | 1.75M | 3.32M | 1.59M | 1.63M | 1.35M | 1.15M | 1.13M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 6.00K | 6.00K | 1.06M | 628.80K | 266.70K | 373.73K | 640.04K | -99.78K | 561.86K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 3.87M | 3.72M | 5.00M | 2.73M | 1.51M | 1.86M | 2.39M | 3.22M | 2.15M | 1.63M | 1.35M | 1.15M | 1.13M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 14.11M | 10.71M | 13.21M | 6.44M | 4.28M | 6.69M | 9.53M | 16.95M | 16.29M | 10.18M | 6.72M | 5.25M | 4.03M | 2.48M | 2.16M | 2.08M | 1.77M | 1.16M |
| Cost & Expenses | 14.11M | 10.71M | 13.47M | 6.55M | 4.40M | 6.76M | 9.61M | 17.02M | 16.39M | 10.18M | 6.72M | 5.25M | 4.03M | 2.48M | 2.16M | 2.08M | 1.79M | 1.16M |
| Interest Income | 0.00 | 242.00K | 82.03K | 23.34K | 19.77K | 38.15K | 69.68K | 166.07K | 384.41K | 357.00K | 617.00K | 223.00K | 191.00K | 14.00K | 12.00K | 58.00K | 52.00K | 10.00K |
| Interest Expense | 0.00 | 23.00K | 13.45K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 26.00K | 194.00K | 105.00K | 0.00 | 0.00 | 1.00K |
| Depreciation & Amortization | 71.00K | 468.00K | 259.53K | 112.60K | 123.91K | 71.03K | 88.17K | 70.45K | 103.55K | 72.00K | 83.00K | 194.00K | 81.00K | 135.00K | 20.00K | 21.00K | 31.00K | 27.00K |
| EBITDA | -13.72M | -9.28M | -9.52M | -4.45M | -2.84M | -5.06M | -6.70M | -11.37M | -11.48M | -9.75M | -6.02M | -4.83M | -3.76M | -2.33M | -2.13M | -1.99M | -1.69M | -1.12M |
| EBITDA Ratio | -4,315.41% | -1,953.89% | -1,959.96% | -1,379.50% | -612.06% | -11,459.25% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -2,976.12% | -1,784.38% | 0.00% |
| Operating Income | -13.79M | -10.24M | -12.83M | -6.12M | -3.80M | -6.70M | -9.61M | -17.02M | -16.39M | -10.18M | -6.72M | -5.25M | -4.03M | -2.46M | -2.15M | -2.02M | -1.17M | -1.15M |
| Operating Income Ratio | -4,337.74% | -2,155.58% | -2,000.42% | -1,405.36% | -632.68% | -11,581.98% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -3,007.46% | -1,832.81% | 0.00% |
| Total Other Income/Expenses | 713.00K | 467.00K | 51.00K | 17.00K | 15.00K | 29.00K | 49.00K | 132.00K | 271.00K | 357.00K | 617.00K | 223.00K | 165.00K | -194.00K | -105.00K | 58.00K | -500.00K | -1.00K |
| Income Before Tax | -13.08M | -9.77M | -12.80M | -6.14M | -3.79M | -6.69M | -9.55M | -20.38M | -16.01M | -9.82M | -6.10M | -5.02M | -3.86M | -2.66M | -2.26M | -1.96M | -2.23M | -1.15M |
| Income Before Tax Ratio | -4,113.52% | -2,057.26% | -1,994.97% | -1,409.46% | -630.04% | -11,556.98% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -2,920.90% | -3,476.56% | 0.00% |
| Income Tax Expense | 1.92M | -1.85M | -1.95M | -1.08M | -693.37K | -1.43M | -1.93M | -3.87M | -3.50M | -2.04M | -1.06M | -846.00K | -621.00K | -342.00K | -476.00K | -411.00K | -259.00K | 0.00 |
| Net Income | -11.17M | -8.27M | -10.85M | -5.06M | -3.09M | -5.26M | -7.62M | -16.51M | -12.51M | -7.78M | -5.04M | -4.18M | -3.24M | -2.31M | -1.78M | -1.55M | -1.97M | -1.15M |
| Net Income Ratio | -3,511.32% | -1,741.89% | -1,691.20% | -1,162.15% | -514.69% | -9,088.76% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -2,307.46% | -3,071.88% | 0.00% |
| EPS | -0.02 | -0.02 | -0.02 | -0.01 | -0.01 | -0.02 | -0.03 | -0.06 | -0.05 | -0.03 | -0.02 | -0.03 | -0.02 | -0.04 | -0.03 | -0.03 | -0.04 | -0.02 |
| EPS Diluted | -0.02 | -0.02 | -0.02 | -0.01 | -0.01 | -0.02 | -0.03 | -0.06 | -0.05 | -0.03 | -0.02 | -0.03 | -0.02 | -0.04 | -0.03 | -0.03 | -0.04 | -0.02 |
| Weighted Avg Shares Out | 584.36M | 537.38M | 488.34M | 373.22M | 268.86M | 268.58M | 268.46M | 282.66M | 264.42M | 264.15M | 254.40M | 138.16M | 131.01M | 65.84M | 60.11M | 55.71M | 51.54M | 55.71M |
| Weighted Avg Shares Out (Dil) | 584.34M | 537.35M | 488.34M | 373.22M | 268.86M | 268.58M | 268.46M | 282.66M | 276.54M | 264.15M | 254.40M | 138.16M | 131.01M | 65.84M | 60.11M | 55.71M | 51.54M | 55.71M |
No news found for: ETXPF
Source: https://incomestatements.info
Category: Stock Reports